Literature DB >> 16895616

Liaisons dangereuses? General anaesthetics and long-term toxicity in the CNS.

M Perouansky1.   

Abstract

We do not know how general anaesthetics cause their desired effects. Contrary to what has been thought until relatively recently, the clinical state of anaesthesia consists of multiple components that are mediated via interaction of the anaesthetic drugs with different targets on the molecular, the cellular, the network and the structural-anatomical levels. The mechanisms by which some of these drugs induce the different components of "anaesthesia" may be rather specific: discrete mutations of single amino acids in specific proteins profoundly affect the ability of certain anaesthetics to achieve specific endpoints. Despite this potential specificity, inhalational anaesthetics are present in the body at very high concentrations during surgical anaesthesia. Due to their lipid solubility, general anaesthetics dissolve in every membrane, penetrate into organelles and interact with numerous cellular structures in multiple ways. A priori, it is therefore not unreasonable to assume that these drugs have the potential to cause insidious changes in the body other than those acute and readily apparent ones that we routinely monitor for. Some changes may wane within a short time after removal of the drug (e.g. the suppression of immune cell function). Others may persist after complete removal of the drug and even become self-propagating (e.g. spread of malignant cells, the beta-oligomerization of proteins), still others may be irreversible (e.g. the induction of apoptosis in the central nervous system) but of unclear significance. This article will focus on evidence for anaesthetic toxicity in the central nervous system, which appears to be susceptible to anaesthetic neurotoxicity primarily at the extremes of ages but via different pathways: in the neonate, during the period of most intense synaptogenesis, anaesthetics can induce excessive apoptosis; in the aging brain subtle cognitive dysfunction can persist long after clearance of the drug and processes resembling neurodegenerative disorders may be accelerated. At all ages, anaesthetics affect gene expression regulating protein synthesis in poorly understood ways. While it seems reasonable to assume that the vast majority of our patients completely restore homeostasis after general anaesthesia, exposure to these drugs probably has more profound and longer-lasting effects on the brain than heretofore imagined.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16895616     DOI: 10.1017/S0265021506001165

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  5 in total

Review 1.  Use of botulinum toxin in the neurology clinic.

Authors:  Erle C H Lim; Raymond C S Seet
Journal:  Nat Rev Neurol       Date:  2010-10-12       Impact factor: 42.937

2.  The use of propofol for medium and long-term sedation in critically ill adult patients: a meta-analysis.

Authors:  Kwok M Ho; Joseph Y Ng
Journal:  Intensive Care Med       Date:  2008-06-25       Impact factor: 17.440

3.  Isoflurane-induced spatial memory impairment by a mechanism independent of amyloid-beta levels and tau protein phosphorylation changes in aged rats.

Authors:  Weiran Liu; Jie Xu; Hui Wang; Chengshi Xu; Chao Ji; Yun Wang; Chunsheng Feng; Xuena Zhang; Zhipeng Xu; Anshi Wu; Zhongcong Xie; Yun Yue
Journal:  Neurol Res       Date:  2012-01       Impact factor: 2.448

4.  Hippocampal glutamate level and glutamate aspartate transporter (GLAST) are up-regulated in senior rat associated with isoflurane-induced spatial learning/memory impairment.

Authors:  Xiangdong Qu; Chengshi Xu; Hui Wang; Jie Xu; Weiran Liu; Yun Wang; Xingyuan Jia; Zhongcong Xie; Zhipeng Xu; Chao Ji; Anshi Wu; Yun Yue
Journal:  Neurochem Res       Date:  2012-10-16       Impact factor: 3.996

5.  Clinical anesthesia causes permanent damage to the fetal guinea pig brain.

Authors:  Sabina Rizzi; Lisa B Carter; Carlo Ori; Vesna Jevtovic-Todorovic
Journal:  Brain Pathol       Date:  2008-01-29       Impact factor: 6.508

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.